Literature DB >> 104340

Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.

J Hyttel.   

Abstract

The uptake of 3H-5-HT in synaptosomes from rat brains was investigated. Addition of DA or NA had only a slight or no effect on the uptake. When the uptake into NA and DA neurons was inhibited by the addition of high concentrations of NA and DA, the uptake of 3H-5-HT was unchanged. This was also found after destruction of NA and DA neurons by 6-hydroxydopamine treatment. Furthermore, the uptake of 3H-5-HT was almost equal in different brain parts containing NA and DA in very different amounts. These observations show that the uptake measured with 3H-5-HT is specific for 5-HT neurons. The present study revealed that citalopram and chlorimipramine inhibited uptake competitively, and in this respect the two drugs were equipotent. Compared with a series of tricyclic thymoleptics, the two drugs were the most potent inhibitors of 5-HT uptake, about 20 to 35 times more active than imipramine and amitriptyline. The metabolites of citalopram were also rather potent. The results obtained in the present study correlate closely with those obtained using inhibition of 14C-5-HT uptake in blood platelets, or using the inhibition of H 75/12-induced 5-HT depletion in rat brain. When rats were treated orally with citalopram or chlorimipramine, the inhibition of 3H-5-HT uptake in synaptosomes derived from these rats was two times greater after citalopram than after chlorimipramine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104340     DOI: 10.1007/bf00429172

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine.

Authors:  D T Wong; J S Horng; F P Bymaster; K L Hauser; B B Molloy
Journal:  Life Sci       Date:  1974-08-01       Impact factor: 5.037

2.  Endogenous levels and turnover of catecholamines in mouse brain after repeated administration of haloperidol.

Authors:  J Hyttel
Journal:  Psychopharmacologia       Date:  1974-04-23

3.  An in vitro model for the study of psychotropic drugs and as a criterion of antidepressant activity.

Authors:  M H Kannengiesser; P Hunt; J P Raynaud
Journal:  Biochem Pharmacol       Date:  1973-01-01       Impact factor: 5.858

4.  Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.

Authors:  S B Ross; A L Renyi
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

5.  Inhibitory effect of two newer antidepressants, Lu 5-003 and Lu 3-010, on serotonin uptake in human blood platelets in vitro.

Authors:  O Lingjaerde
Journal:  Psychopharmacologia       Date:  1970

6.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine.

Authors:  A Carlsson; H Corrodi; K Fuxe; T Hökfelt
Journal:  Eur J Pharmacol       Date:  1969-03       Impact factor: 4.432

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.

Authors:  S B Ross; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

9.  Hepatotoxicity of citalopram in rats and first-pass metabolism.

Authors:  K Fredricson Overø; O Svendsen
Journal:  Arch Toxicol Suppl       Date:  1978

10.  Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover.

Authors:  J Hyttel
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-03
View more
  19 in total

1.  Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.

Authors:  A L Ask; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

2.  Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.

Authors:  J Arnt; A V Christensen; J Hyttel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

3.  Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.

Authors:  J B Lassen; J Lund; I Søndergaard
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain.

Authors:  Y Chaput; C de Montigny; P Blier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

5.  The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer.

Authors:  J Hyttel; K P Bøgesø; J Perregaard; C Sánchez
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.

Authors:  J Hyttel; K F Overø; J Arnt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Preliminary studies of the kinetics of citalopram in man.

Authors:  K F Overø
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

8.  Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine.

Authors:  C J Schmidt; J W Gibb
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

9.  The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients.

Authors:  H Beving; L Bjerkenstedt; R Malmgren; P Olsson; G Unge
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects.

Authors:  M Lader; A Melhuish; G Frcka; K Fredricson Overø; V Christensen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.